Pfizer vs BMY: Which Oncology Drugmaker Is a Better Choice for Now?

• click to rate

  Posted by Two Blokes Jun 20 - Filed in Stock - 6 views
  
  Pfizer's broader portfolio and higher dividend yield give it an edge over Bristol Myers in the oncology showdown.